← Back to Search

Behavioral Intervention

Intervention (App) Group for COVID-19

N/A
Waitlist Available
Led By Yael Hirsch-Moverman, PhD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at study completion (about 1 month after enrollment)
Awards & highlights

Study Summary

This trial studies how an app can help people learn about, think about, and act on COVID-19 self-testing.

Eligible Conditions
  • COVID-19
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at study completion (about 1 month after enrollment)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at study completion (about 1 month after enrollment) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
COVID-19 Self-Testing Knowledge, Attitudes, and Practices Questionnaire Score - study completion
COVID-19 Self-Testing Knowledge, Attitudes, and Practices Questionnaire Score - study initiation

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention (App) GroupExperimental Treatment1 Intervention
Participants in this group will be given access to a COVID-19 self-testing app (SMARTest). Access to the app, given exclusively to this group, will be in addition to the 12 COVID-19 self-test kits participants receive.
Group II: Control (No App) GroupActive Control1 Intervention
Participants in this group will not be given access to the COVID-19 self-testing app (SMARTest). Participants will only receive the 12 COVID-19 self-test kits.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SMARTest mobile app for COVID-19 self-testing
2023
N/A
~100

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,431 Previous Clinical Trials
2,460,731 Total Patients Enrolled
23 Trials studying COVID-19
12,129 Patients Enrolled for COVID-19
Yael Hirsch-Moverman, PhDPrincipal InvestigatorColumbia University
1 Previous Clinical Trials
562 Total Patients Enrolled
Jessica Justman, MDPrincipal InvestigatorColumbia University
7 Previous Clinical Trials
42,659 Total Patients Enrolled
2 Trials studying COVID-19
26,830 Patients Enrolled for COVID-19

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available slots for participants in this research project?

"As noted on clinicaltrials.gov, this research programme is actively recruiting participants for the trial which was published in January of 2021 and most recently revised at the end of that same month."

Answered by AI

How many participants are currently involved in this experiment?

"Indeed, clinicaltrials.gov reveals that the trial is currently welcoming patients. This study was initially publicized on January 1st 2023 and was most recently updated on 25th of the same month. It requires 100 volunteers from a solitary location to participate in this research project."

Answered by AI

Who else is applying?

What state do they live in?
California
What site did they apply to?
ICAP Harlem Prevention Center
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
COVID-19 Self-testing Study
Yael Hirsch-Moverman 2023. "COVID-19 Self-testing Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05701878.
~50 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top